Methods of medical treatment for excess phosphate using guanidin

Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 7811, 424 7812, 424 7816, 424 7835, A61K 3174

Patent

active

061327069

ABSTRACT:
The invention provides a physiologically acceptable polymer comprising a backbone to which are attached guanidino groups, the polymer having a minimum molecular weight of 10,000. The invention also extends to foodstuffs and pharmaceutical compositions comprising the physiologically acceptable polymer. Such foodstuffs and compositions are of value in controlling phosphate levels in the body.

REFERENCES:
patent: 2945006 (1960-07-01), Minsk et al.
patent: 3734939 (1973-05-01), Schaefer
patent: 4071459 (1978-01-01), Cohen et al.
patent: 4159898 (1979-07-01), Cohen et al.
patent: 4478984 (1984-10-01), Bryan
patent: 5496545 (1996-03-01), Holmes-Farley et al.
patent: 5667775 (1997-09-01), Holmes-Farley et al.
U.S. application No. 08/895,087, Hider et al., filed Jul. 15, 1997.
Patent Abstracts of Japan, vol. 12 No. 103 (C-485)(2950) Apr. 5, 1988, abstracting JP-A 62-230806.
Patent Abstracts of Japan, vol. 6 No. 4598 (C-77)(4598) 1977, abstracting JP-A 52-139050.
Patent Abstracts of Japan, vol. 9 No. 125 (C-283)(1848) May 30, 1985, abstracting JP-A 60-011509.
Patent Abstracts of Japan, vol. 4 No. 119 (C-22)(601), Aug. 23, 1980, abstracting JP-A 55-073706.
Derwent Japan Patent Abstract WPI Accession No. 85-053864/09 abstracting JP-A 60-011509, 1985.
Derwent Japan Patent Abstract WPI Accession No. 80-684066/39, abstracting JP-A 55-104357, 1980.
Derwent Japan Patent Abstract WPI Accession No. 80-33546C/19, abstracting JP-A 55-042506, 1980.
Derwent Japan Patent Abstract WPI Accession No. 80-26758C/15, abstracting SU-A 615087, 1980.
A. Akelah and D.C. Sherrington, "Application of Functionalized Polymers in Organic Synthesis" Chem. Rev. 81, 557-587 (1981).
E. Batres and M.L. Hallensleben, "Poly(amidine)s and Poly(guanidine)s--Synthesis and Some Properties", Polymer Bulletin 1, 715-722(1979).
Chemical Abstracts 85, No. 144224d(1976) abstracting SU-A 523,112.
Y. Yamamoto and S. Kojima, Chapter 10 "Synthesis and Chemistry of Guanidine Derivatives" in S. Patai and Z. Rappoport (eds.), "The Chemistry of Amidines and Imidates", John Wiley & Sons Ltd., pp. 485-526 (1991).
P.Haddad and P.E. Jackson, "Ion Chromatography: principles and applications", Journal of Chromatography Library 46, 48-52 (1990).
Burt et al., "Ion-Exchange Resins as Potential Phosphate-Binding Agents for Renal Failure Patients: Effect of the Physicochemical Properties of Resins on Phosphate and Bile Salt Binding", Journal of Pharmaceutical Science 76, No. 5, 379-383 (1987).
McGary et al., "Polycation as an Alternative Osmotic Agent and Phosphate Binder in Peritoneal Dialysis", Uremia Investigation 8(2), 79-84 (1984-85).
J.A. Delmez and E. Slatopolsky, "Hyperphosphatemia: Its Consequences and Treatment in Patients with Chronic Renal Disease", American Journal of Kidney Diseases XIX, No. 4, 303-317 (1992).
G. Semenza, "Chromatographie von Polyelektrolyten V. Aminoathyl-Cellulose und Guanidinoathyl-Cellulose", Helv. Chim. Acta 43, 1057-1068 (1960), with partial translation.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of medical treatment for excess phosphate using guanidin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of medical treatment for excess phosphate using guanidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of medical treatment for excess phosphate using guanidin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-465654

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.